A Non-Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus - Concepedia

Concepedia

Publication | Closed Access

A Non-Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus

79

Citations

26

References

2014

Year

Pablo Vial, Francisca Valdivieso, Mario Calvo, María Luisa Rioseco, Raúl Riquelme, Andres Araneda, Vinko Tomicić, Jerónimo Graf, Laura Gallego Paredes, Matías Florenzano,

Antiviral Therapy

Abstract

Human ANDV immune plasma infusion appears safe for HCPS. We observed a decrease in CFR in treated cases with borderline significance that will require further studies for confirmation.

References

	Year	Citations

Page 1